Apr 29 |
Intellia Therapeutics to Present Updated Data from Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Congress 2024
|
Apr 25 |
Intellia (NTLA) to Report Q1 Earnings: What's in the Cards?
|
Apr 25 |
Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q1 Earnings Expected to Decline
|
Apr 14 |
2 Stocks Down 30% to Buy Right Now
|
Apr 12 |
Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week.
|
Apr 9 |
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
|
Apr 6 |
Intellia Therapeutics (NASDAQ:NTLA shareholders incur further losses as stock declines 9.9% this week, taking three-year losses to 65%
|